Scientific Advisory Board
Max Planck Institutes are assessed by an independent scientific advisory board on a regular basis to ensure consistent, high-quality research. The board members are selected by the president of the Max Planck Society in the light of suggestions from the institute, for a maximum term of six years.
The scientific advisory board of the Max Planck Institute for Medical Research currently includes the following members.
Kyoto University, Institute for Integrated Cell-Material Sciences
more
University of Cambridge, Department of Chemical Engineering and Biotechnology
more
University of Leipzig, Soft Matter Physics Division Biophysics
more
Universität Zürich, Department of Biochemistry
more
Oregon Health & Science University
more
University of Michigan, Life Sciences Institute
more
Westfälische Wilhelms-Universität Münster, Institute for Physiological Chemistry and Pathobiochemistry
more
University of California, Department of Chemistry and Biochemistry
more
University of California, San Diego, Department of Pharmacology
more